0001004878-15-000198.txt : 20150623
0001004878-15-000198.hdr.sgml : 20150623
20150623110645
ACCESSION NUMBER: 0001004878-15-000198
CONFORMED SUBMISSION TYPE: 8-K
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150622
ITEM INFORMATION: Submission of Matters to a Vote of Security Holders
FILED AS OF DATE: 20150623
DATE AS OF CHANGE: 20150623
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEL SCI CORP
CENTRAL INDEX KEY: 0000725363
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 840916344
STATE OF INCORPORATION: CO
FISCAL YEAR END: 0930
FILING VALUES:
FORM TYPE: 8-K
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11889
FILM NUMBER: 15946397
BUSINESS ADDRESS:
STREET 1: 8229 BOONE BLVD .
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
BUSINESS PHONE: 7035069460
MAIL ADDRESS:
STREET 1: 8229 BOONE BLVD.
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
FORMER COMPANY:
FORMER CONFORMED NAME: INTERLEUKIN 2 INC
DATE OF NAME CHANGE: 19880317
8-K
1
form8kitem507annmting6-15.txt
FORM 8-K ITEM 5.07 ANNUAL MEETING
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): June 22, 2015
CEL-SCI CORPORATION
--------------------------------------
(Exact name of Registrant as specified in its charter)
Colorado 0-11503 84-091634
-------------------- ------------------ ----------------
(State or other jurisdiction (Commission File No.) (IRS Employer
of incorporation) Identification No.)
8229 Boone Boulevard, Suite 802
Vienna, Virginia 22182
---------------------------------------------------
(Address of principal executive offices, including Zip Code)
Registrant's telephone number, including area code: (703) 506-9460
N/A
----------------------------------------------------
(Former name or former address if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligations of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b)
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-14c))
Item 5.07. Submission of Matters to a Vote of Securities Holders.
The annual meeting of CEL-SCI's shareholders was held on June 22, 2015. At
the meeting the following persons were elected as directors for the upcoming
year:
Votes
------------------------ Broker
Name For Against Non-Votes
---- --- ------- ---------
Maximilian de Clara 24,855,097 1,674,328 40,338,668
Geert R. Kersten 25,576,797 952,628 40,338,668
Alexander G. Esterhazy 22,833,534 3,695,891 40,338,668
Peter R. Young 23,030,286 3,499,139 40,338,668
Bruno Baillavoine 25,783,505 745,920 40,338,668
At the meeting the following were ratified by CEL-SCI's shareholders:
(1) the adoption of CEL-SCI's 2015 Non-Qualified Stock Option Plan;
(2) the adoption of CEL-SCI's 2015 Stock Bonus Plan;
(3) the adoption of CEL-SCI's 2015 Stock Compensation Plan;
(4) the extension of CEL-SCI's Shareholder Rights Plan; and
(5) ratification of the appointment of BDO USA, LLP as CEL-SCI's
independent registered public accounting firm for the fiscal year
ending September 30, 2015;
The following is a tabulation of votes cast with respect to proposals 1, 2,
3, 4 and 5:
Votes
---------------------------------- Broker
Proposal For Against Abstain Non-Votes
-------- --- ------- ------- ---------
(1) 20,734,651 5,331,348 463,426 40,338,668
(2) 23,126,729 2,950,765 451,931 40,338,668
(3) 23,215,664 2,868,086 445,675 40,338,668
(4) 22,560,712 3,757,778 210,935 40,338,668
(5) 65,004,137 1,172,789 691,167 0
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: June 23, 2015 CEL-SCI CORPORATION
By: /s/ Patricia B. Prichep
--------------------------------
Patricia B. Prichep
Senior Vice President of Operations